Data / Drug companies / Powder, for suspension
Companies that list powder, for suspension products: 102 companies and 470 products in the FDA NDC directory
The FDA National Drug Code Directory lists 470 products that are powder, for suspension products from 102 companies. The ten largest listers hold 42.8% of them, and the newest started marketing on October 15, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies
- 102
- Products
- 470
- Drugs by generic name
- 40
- Main marketing category
- Generic drugs (ANDA)
Companies that list powder, for suspension products
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 47 | powder, for suspension | Generic drugs (ANDA) | January 16, 2026 |
| NuCare Pharmaceuticals,Inc. | 34 | powder, for suspension | Generic drugs (ANDA) | August 6, 2018 |
| Preferred Pharmaceuticals Inc. | 22 | powder, for suspension | Generic drugs (ANDA) | July 31, 2026 |
| Aurobindo Pharma Limited | 19 | powder, for suspension | Generic drugs (ANDA) | June 13, 2017 |
| Chartwell RX, LLC | 15 | powder, for suspension | Generic drugs (ANDA) | February 28, 2018 |
| Proficient Rx LP | 14 | powder, for suspension | Generic drugs (ANDA) | December 17, 2010 |
| Proficient Rx LP | 13 | powder, for suspension | Generic drugs (ANDA) | August 6, 2018 |
| Teva Pharmaceuticals USA, Inc. | 13 | powder, for suspension | Generic drugs (ANDA) | July 10, 2019 |
| Epic Pharma, LLC | 12 | powder, for suspension | Generic drugs (ANDA) | August 2, 2022 |
| Lupin Pharmaceuticals, Inc. | 12 | powder, for suspension | Generic drugs (ANDA) | May 4, 2026 |
| Aurobindo Pharma Limited | 10 | powder, for suspension | Generic drugs (ANDA) | June 9, 2026 |
| NorthStar Rx LLC | 9 | powder, for suspension | Generic drugs (ANDA) | April 25, 2013 |
| Ascend Laboratories, LLC | 8 | powder, for suspension | Generic drugs (ANDA) | August 24, 2023 |
| Bryant Ranch Prepack | 8 | powder, for suspension | Generic drugs (ANDA) | October 20, 2021 |
| Direct_Rx | 8 | powder, for suspension | Generic drugs (ANDA) | October 21, 2022 |
| Rising Pharma Holdings, Inc. | 8 | powder, for suspension | Generic drugs (ANDA) | April 25, 2013 |
| Asclemed USA, Inc. | 7 | powder, for suspension | Generic drugs (ANDA) | February 21, 2018 |
| Puracap Laboratories LLC DBA Blu Pharmaceuticals | 7 | powder, for suspension | Generic drugs (ANDA) | May 30, 2025 |
| Zydus Lifesciences Limited | 7 | powder, for suspension | Generic drugs (ANDA) | October 27, 2022 |
| Biogen Inc. | 6 | powder, for suspension | Drugs for further processing | May 5, 2014 |
| Bryant Ranch Prepack | 6 | powder, for suspension | Generic drugs (ANDA) | August 10, 2023 |
| Hawaii Repack, Inc. | 6 | powder, for suspension | Generic drugs (ANDA) | December 20, 2011 |
| Hikma Pharmaceuticals USA Inc. | 6 | powder, for suspension | Generic drugs (ANDA) | December 1, 2007 |
| Sandoz Inc | 6 | powder, for suspension | Generic drugs (ANDA) | March 26, 2007 |
| Sichuan Xieli Pharmaceutical Co., Ltd. | 6 | powder, for suspension | Bulk ingredients for compounding | December 19, 2019 |
| Slate Run Pharmaceuticals, LLC | 6 | powder, for suspension | Generic drugs (ANDA) | March 1, 2024 |
| Zhejiang Poly Pharm. Co., Ltd. | 6 | powder, for suspension | Generic drugs (ANDA) | April 11, 2025 |
| Camber Pharmaceuticals, Inc. | 5 | powder, for suspension | Generic drugs (ANDA) | August 8, 2025 |
| Zydus Pharmaceuticals USA Inc. | 5 | powder, for suspension | Generic drugs (ANDA) | October 27, 2022 |
| Ani Pharmaceuticals, Inc. | 4 | powder, for suspension | Generic drugs (ANDA) | January 15, 2026 |
| Dr. Reddy's Laboratories Inc. | 4 | powder, for suspension | Generic drugs (ANDA) | July 15, 2024 |
| Macleods Pharmaceuticals Limited | 4 | powder, for suspension | Generic drugs (ANDA) | November 21, 2024 |
| NorthStar RxLLC | 4 | powder, for suspension | Generic drugs (ANDA) | October 1, 2026 |
| Par Health USA, LLC | 4 | powder, for suspension | Generic drugs (ANDA) | September 15, 2005 |
| Strides Pharma Science Limited | 4 | powder, for suspension | Generic drugs (ANDA) | September 1, 2026 |
| Vifor Pharma, Inc. | 4 | powder, for suspension | New drug applications (NDA) | October 2, 2024 |
| AiPing Pharmaceutical, Inc. | 3 | powder, for suspension | Generic drugs (ANDA) | September 1, 2026 |
| Amneal Pharmaceuticals NY LLC | 3 | powder, for suspension | Generic drugs (ANDA) | August 5, 2022 |
| Amneal Pharmaceuticals NY LLC | 3 | powder, for suspension | Generic drugs (ANDA) | May 13, 2024 |
| Amphastar Nanjing Pharmaceuticals, Inc. | 3 | powder, for suspension | Bulk ingredients | June 1, 2014 |
| AstraZeneca Pharmaceuticals LP | 3 | powder, for suspension | New drug applications (NDA) | December 1, 2021 |
| Devatis, Inc. | 3 | powder, for suspension | Generic drugs (ANDA) | November 1, 2024 |
| E-Z-Em Canada Inc | 3 | powder, for suspension | New drug applications (NDA) | April 30, 2019 |
| Mylan Pharmaceuticals Inc. | 3 | powder, for suspension | Authorized generics (NDA) | December 16, 2013 |
| Novadoz Pharmaceuticals LLC | 3 | powder, for suspension | Generic drugs (ANDA) | July 24, 2025 |
| NuCare Pharmaceuticals, Inc. | 3 | powder, for suspension | Generic drugs (ANDA) | June 19, 2006 |
| Pfizer Laboratories Div Pfizer Inc | 3 | powder, for suspension | New drug applications (NDA) | October 19, 1995 |
| Zydus Pharmaceuticals USA Inc. | 3 | powder, for suspension | Generic drugs (ANDA) | April 22, 2021 |
| Ajanta Pharma USA Inc. | 2 | powder, for suspension | Generic drugs (ANDA) | April 6, 2020 |
| Amneal Pharmaceuticals of New York LLC | 2 | powder, for suspension | Generic drugs (ANDA) | November 20, 2020 |
| Biocodex, Inc. | 2 | powder, for suspension | New drug applications (NDA) | August 21, 2018 |
| Bionpharma Inc. | 2 | powder, for suspension | Generic drugs (ANDA) | September 1, 2021 |
| Bryant Ranch Prepack | 2 | powder, for suspension | Generic drugs (ANDA) | October 20, 2021 |
| Dr. Reddy's Laboratories Inc. | 2 | powder, for suspension | Generic drugs (ANDA) | July 15, 2024 |
| Genentech, Inc. | 2 | powder, for suspension | New drug applications (NDA) | March 21, 2011 |
| Genzyme Corporation | 2 | powder, for suspension | New drug applications (NDA) | August 12, 2009 |
| Hy-Gro Chemicals Pharmtek PVT LTD | 2 | powder, for suspension | Bulk ingredients for compounding | July 19, 2020 |
| Lannett Company, Inc. | 2 | powder, for suspension | Generic drugs (ANDA) | June 2, 2025 |
| Micro Labs Limited | 2 | powder, for suspension | Generic drugs (ANDA) | April 1, 2026 |
| Novartis Pharmaceuticals Corporation | 2 | powder, for suspension | New drug applications (NDA) | September 27, 2018 |
| Precision Dose, Inc. | 2 | powder, for suspension | Generic drugs (ANDA) | April 25, 2024 |
| Proficient Rx LP | 2 | powder, for suspension | Generic drugs (ANDA) | September 15, 2014 |
| Redpharm Drug | 2 | powder, for suspension | Generic drugs (ANDA) | August 6, 2018 |
| Remedyrepack Inc. | 2 | powder, for suspension | Generic drugs (ANDA) | November 25, 2025 |
| Roerig | 2 | powder, for suspension | New drug applications (NDA) | March 28, 2003 |
| Sanofi-Aventis U.S. LLC | 2 | powder, for suspension | Authorized generics (NDA) | January 1, 2018 |
| Santarus, Inc. | 2 | powder, for suspension | New drug applications (NDA) | June 15, 2014 |
| State Health Services, Texas Department of | 2 | powder, for suspension | Generic drugs (ANDA) | December 28, 2010 |
| Tagi Pharma, Inc. | 2 | powder, for suspension | Generic drugs (ANDA) | March 10, 2021 |
| Actavis Pharma, Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | August 17, 2020 |
| Alvogen Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | November 1, 2017 |
| Amneal Pharmaceuticals LLC | 1 | powder, for suspension | Generic drugs (ANDA) | November 29, 2013 |
| Atlantic Biologicals Corp. | 1 | powder, for suspension | Generic drugs (ANDA) | April 14, 2014 |
| Biocon Pharma Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | September 1, 2023 |
| BluePoint Laboratories | 1 | powder, for suspension | Generic drugs (ANDA) | June 18, 2021 |
| CMP Pharma, Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | January 19, 1989 |
| Carnegie Pharmaceuticals LLC | 1 | powder, for suspension | Generic drugs (ANDA) | August 10, 2023 |
| Chartwell Governmental & Specialty RX, LLC. | 1 | powder, for suspension | Generic drugs (ANDA) | July 16, 2008 |
| Direct RX | 1 | powder, for suspension | Generic drugs (ANDA) | January 1, 2014 |
| Evonik Corporation | 1 | powder, for suspension | Drugs for further processing | January 22, 2025 |
| Glenmark Pharmaceuticals Inc., USA | 1 | powder, for suspension | Generic drugs (ANDA) | July 16, 2018 |
| Golden State Medical Supply, Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | April 20, 2021 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | September 5, 2023 |
| Hikma Pharmaceuticals USA Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | June 3, 2015 |
| Kesin Pharma Corporation | 1 | powder, for suspension | Generic drugs (ANDA) | August 10, 2023 |
| Lupin Pharmaceuticals,Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | June 1, 2016 |
| Merck Sharp & Dohme LLC | 1 | powder, for suspension | Biologics (BLA) | August 24, 1990 |
| Merck Sharp & Dohme LLC | 1 | powder, for suspension | New drug applications (NDA) | December 17, 2015 |
| Merck Sharp & Dohme LLC | 1 | powder, for suspension | New drug applications (NDA) | June 8, 2021 |
| Navinta LLC | 1 | powder, for suspension | Generic drugs (ANDA) | April 22, 2021 |
| Novo Nordisk Production Ireland Limited | 1 | powder, for suspension | Drugs for further processing | September 30, 2015 |
| Oryza Pharmaceuticals Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | October 19, 2025 |
| Professional Compounding Centers of America DBA Pcca | 1 | powder, for suspension | Bulk ingredients for compounding | June 10, 2021 |
| Quagen Pharmaceuticals LLC | 1 | powder, for suspension | Generic drugs (ANDA) | August 6, 2026 |
| Rising Pharma Holdings, Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | October 15, 2026 |
| Rising Pharma Holdings, Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | August 20, 2026 |
| Sunrise Pharmaceutical, Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | January 24, 2017 |
| Upsher-Smith Laboratories, LLC | 1 | powder, for suspension | Generic drugs (ANDA) | February 1, 1996 |
| Upsher-Smith Laboratories, LLC | 1 | powder, for suspension | Generic drugs (ANDA) | June 16, 2023 |
| Viatris Specialty LLC | 1 | powder, for suspension | New drug applications (NDA) | October 25, 2024 |
Drugs most often listed
| Drug | Products here | Companies listing it |
|---|---|---|
| Famotidine | 21 | 138 |
| Omeprazole | 2 | 106 |
| Doxycycline | 3 | 63 |
| Sildenafil | 5 | 53 |
| Hydrochlorothiazide | 1 | 51 |
| Fluconazole | 11 | 48 |
| Azithromycin | 48 | 41 |
| Oseltamivir phosphate | 15 | 37 |
| Mycophenolate mofetil | 12 | 37 |
| Cephalexin | 8 | 36 |
| Amoxicillin | 89 | 35 |
| Amoxicillin and clavulanate potassium | 54 | 35 |
| Sevelamer carbonate | 13 | 35 |
| Voriconazole | 7 | 34 |
| Posaconazole | 1 | 29 |
| Linezolid | 1 | 28 |
| Cefdinir | 38 | 25 |
| Sildenafil citrate | 6 | 24 |
| Azithromycin dihydrate | 7 | 20 |
| Cefadroxil | 8 | 15 |
| Cholestyramine | 26 | 14 |
| Sodium polystyrene sulfonate | 11 | 13 |
| Colesevelam hydrochloride | 4 | 12 |
| Omeprazole and sodium bicarbonate | 8 | 11 |
| Cefprozil | 10 | 7 |
| Cefixime | 4 | 7 |
| Eltrombopag olamine | 4 | 7 |
| Aprepitant | 1 | 7 |
| Cholestyramine powder for suspension | 4 | 4 |
| Cholestyramine light | 5 | 2 |
| Sodium zirconium cyclosilicate | 4 | 2 |
| Barium sulfate | 3 | 2 |
| Choleystyramine light | 2 | 2 |
| Polyethylene glycol | 1 | 2 |
| Patiromer | 4 | 1 |
| Sevelamer carbonate for oral suspension | 2 | 1 |
| Stiripentol | 2 | 1 |
| Amoxicillin oral susp | 1 | 1 |
| Amoxicillin/clav pot oral susp | 1 | 1 |
| Bacillus calmette-guerin | 1 | 1 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.